 |
|
|
| |
Suppressing Asymptomatic CMV with Letermovir
Reshapes Cardiometabolic Proteome in Treated HIV
|
| |
| |
CROI 2024 March 3-6 Denver
Sara Gianella1, Douglas W. Kitch2, Gabriele Beck-Engeser3, Milenka V. Meneses1, Scott Letendre1, Michael P. Dube4, Lawrence Fox5, John R. Koethe6, Priscilla Y. Hsue3, Ahmed A. Tawakol7, Adam Olshen3, Michael L. Freeman8, Davey M. Smith1, and Peter W. Hunt3 for the ACTG 5383 (ELICIT) Trial Team
1University of California San Diego, CA, USA, 2Harvard University, Boston, MA, USA, 3University of California San Francisco, CA, USA, 4University of Southern California, Los Angeles, CA, USA, 5National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA, 6Vanderbilt University, Nashville, TN, USA, 7Massachusetts General Hospital, Boston, MA, USA, 8Case Western Reserve University, Cleveland, OH, USA
|
| |
|
|
|
|
|
